881675-06-5

Usage

Molecular structure

The compound contains a pyrrole ring, a carboxylic acid group, a sulfonyl group, a methyl group, a phenyl group, and an ethyl ester group.

Molecular weight

377.89 g/mol

Physical state

Solid

Solubility

Insoluble in water, soluble in organic solvents such as ethanol, methanol, and acetone.

Melting point

Not readily available, but it is expected to have a high melting point due to the presence of the sulfonyl and phenyl groups.

Reactivity

The compound may undergo reactions such as ester hydrolysis, nucleophilic substitution, and electrophilic aromatic substitution due to the presence of functional groups.

Uses

The compound has potential uses in drug development, agrochemicals, and material sciences as a building block for synthesizing other compounds.

Further research and testing

The specific properties and potential uses of the compound would depend on further research and testing to determine its pharmacological and chemical properties.

Upstream product

• 3652-48-0 ethyl 2-methyl-5-phenyl-1H-pyrrole-3-carboxylate 
• 2888-06-4 3-chlorophenylsulfonyl chloride 

Downstream Products

• 881675-70-3 {1-[(3-chlorophenyl)sulfonyl]-2-methyl-5-phenyl-1H-pyrrol-3-yl}methanol 

Relevant academic research and scientific papers

Proton pump inhibitors

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R 1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R 2 , R 3 and R 4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R 5 and R 6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.

PROTON PUMP INHIBITORS

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R2, R3 and R4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R5 and R6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.